Fenwick & West represented Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the…
Dermira’s $193.8 Million Follow-On Offering

Fenwick & West represented Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.